MedTrace Logo

Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia

NCT07443800 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-02

No results posted yet for this study

Summary

The overall objective of the research project presented here is to assess the prevalence of fibromyalgia in patients being treated for ADHD, the prevalence of ADHD in patients being treated for fibromyalgia, and the neurobiological correlates of ADHD-fibromyalgia comorbidity.

Conditions

  • Attention Deficit Disorder With or Without Hyperactivity

Interventions

OTHER

Samples, questionnaires, assessment of pain and sensitivity to pain

Blood and urine samples including metabolomic analyses. Completing self-assessment questionnaires. Assessment of sensitivity to mechanical pain (by using the Von Frey monofilament test)

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-04-01
Completion
2026-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07443800 on ClinicalTrials.gov